Department of Medicine, Gastroenterology, Shinshu University School of Medicine, Matsumoto, Japan.
Dig Endosc. 2013 Mar;25(2):189-96. doi: 10.1111/j.1443-1661.2012.01344.x. Epub 2012 Jul 2.
Endoscopic retrograde cholangiopancreatography (ERCP) is subject to several complications that include a lengthy procedure time, technical difficulty, and active bowel movement induced by air insufflation. In ERCP carried out by non-expert endoscopists who are prone to excessive luminal insufflation, insufflation with carbon dioxide (CO2 ) may provide better and safer outcomes. We aimed to assess the efficacy and safety of CO2 insufflation during ERCP by non-expert endoscopists.
This study included 208 consecutive patients who received ERCP, excluding those in poor general health or with obstructive lung disease. The first operator for each patient was a non-expert endoscopist having done 50 or fewer ERCP procedures. Primary outcomes were the changes in cardiopulmonary state during ERCP. Secondary outcomes were ERCP complications. We designed a single-center, randomized, prospective, double-blind, controlled trial with CO2 and air insufflation during ERCP.
CO2 insufflation did not affect overall procedure progression or results. A positive correlation was observed between procedure time and change in maximal systolic blood pressure from baseline among patients in the air insufflation group, but not in the CO2 insufflation group (correlation coefficient 0.408 vs 0.114, change in the maximal systolic blood pressure from baseline +4.2 vs+1.2 mmHg/10 min). This was consistent with our findings in patients treated by the first operator alone. The occurrence rate of post-ERCP pancreatitis tended to be lower in the CO2 group than the air group (4/102 [3.9%]vs 0/106 [0%], P = 0.056).
CO2 insufflation during ERCP by non-expert endoscopists is recommended from the standpoints of efficacy and safety.
内镜逆行胰胆管造影术(ERCP)可能出现多种并发症,包括操作时间长、技术难度大、因注气引起肠蠕动活跃等。在经验不足的内镜医师进行 ERCP 时,过度的腔内注气可能导致并发症的发生,而二氧化碳(CO2 )注气可能提供更好、更安全的结果。我们旨在评估非专家内镜医师行 ERCP 时 CO2 注气的疗效和安全性。
本研究纳入了 208 例连续接受 ERCP 的患者,排除一般健康状况不佳或有阻塞性肺疾病的患者。每位患者的第一操作医师均为经验不足、行 ERCP 操作少于 50 次的内镜医师。主要结局为 ERCP 过程中心肺状态的变化。次要结局为 ERCP 相关并发症。我们设计了一项单中心、随机、前瞻性、双盲、对照临床试验,比较 ERCP 时 CO2 与空气注气。
CO2 注气并不影响整体操作进程或结果。在空气注气组中,从基线到最大收缩压的变化与操作时间呈正相关,但在 CO2 注气组中无此相关性(相关系数 0.408 比 0.114,从基线的最大收缩压变化+4.2 比+1.2mmHg/10min)。这与我们观察到的由第一操作医师单独治疗的患者的结果一致。CO2 组术后胰腺炎的发生率较空气组有降低趋势(4/102[3.9%]比 0/106[0%],P=0.056)。
从疗效和安全性的角度来看,推荐非专家内镜医师在 ERCP 时使用 CO2 注气。